In mice fed with a high-fat diet, canagliflozin suppresses the obesity-induced accumulation of macrophages along with a decrease in IL-6, and TNFα gene expression in the nodose ganglion and the hypothalamus, and a decrease of TNFα in skeletal muscle [185]. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.